Anika Therapeutics, Inc. Quarterly Costs and Expenses in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Anika Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q3 2024.
  • Anika Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $29.5M, a 9.69% decline year-over-year.
  • Anika Therapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $176M, a 34.3% increase year-over-year.
  • Anika Therapeutics, Inc. annual Costs and Expenses for 2023 was $191M, a 68.8% increase from 2022.
  • Anika Therapeutics, Inc. annual Costs and Expenses for 2022 was $113M, a 40.6% increase from 2021.
  • Anika Therapeutics, Inc. annual Costs and Expenses for 2021 was $80.3M, a 17.5% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $176M $29.5M -$3.16M -9.69% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $180M $27.2M -$5.4M -16.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $185M $29.7M -$5.71M -16.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $191M $90.1M +$59.3M +193% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $131M $32.6M +$4.04M +14.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $127M $32.6M +$4.36M +15.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $123M $35.4M +$10M +39.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $113M $30.8M +$3.54M +13% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $109M $28.6M +$6.85M +31.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $103M $28.2M +$16.6M +143% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $86M $25.4M +$5.64M +28.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $80.3M $27.3M -$7.44M -21.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 $87.8M $21.7M -$3.55M -14% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $91.3M $11.6M -$11.6M -50% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $103M $19.7M +$5.61M +39.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $97.3M $34.7M +$38.5M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 $58.9M $25.3M +$7.62M +43.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $51.3M $23.3M +$4.78M +25.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $46.5M $14.1M -$5.14M -26.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $51.6M -$3.78M +$10.3M +73.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $41.3M $17.6M -$566K -3.11% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $41.9M $18.5M -$799K -4.14% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $42.7M $19.2M -$9.86M -33.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $52.5M -$14.1M -$33.7M -172% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-04-26
Q3 2018 $86.3M $18.2M +$1.3M +7.68% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 $85M $19.3M +$3.57M +22.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 $81.4M $29.1M +$13.7M +89.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $67.7M $19.7M +$3.67M +23% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-06
Q3 2017 $64M $16.9M +$4.82M +39.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $59.2M $15.7M +$2.62M +20% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $56.6M $15.4M +$3.81M +32.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $52.8M $16M +$2.16M +15.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $50.6M $12.1M +$1.55M +14.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 $49.1M $13.1M +$2.64M +25.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 $46.4M $11.6M +$1.56M +15.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $44.9M $13.8M +$2.66M +23.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $42.2M $10.5M -$1.22M -10.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 $43.4M $10.5M -$597K -5.39% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $44M $10M -$124K -1.22% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $44.1M $11.2M +$347K +3.21% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-24
Q3 2014 $43.8M $11.8M +$1.78M +17.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $42M $11.1M -$358K -3.13% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $42.4M $10.1M -$95.9K -0.94% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q4 2013 $42.5M $10.8M -$3.99M -27% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 $46.5M $9.99M -$2.05M -17% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $48.5M $11.4M -$2.06M -15.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $50.6M $10.2M -$1.06M -9.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 $51.6M $14.8M +$1.29M +9.51% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $50.4M $12M -$1.6M -11.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $52M $13.5M +$1.03M +8.25% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $50.9M $11.3M +$117K +1.04% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q4 2011 $50.8M $13.5M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 $13.6M +$1.85M +15.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $12.5M -$232K -1.83% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $11.2M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
Q3 2010 $11.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $12.7M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.